Literature DB >> 3190973

Anticonvulsive properties of pregnanolone emulsion compared with althesin and thiopentone in mice.

S Høgskilde1, J Wagner, P Carl, N Anker, H R Angelo, M B Sørensen.   

Abstract

The anticonvulsive properties of pregnanolone (as an emulsion) were evaluated in mice and compared with similar properties of Althesin and thiopentone. Pregnanolone emulsion was found to antagonize convulsions induced by the GABA antagonists pentetrazole, bicuculline and picrotoxin and by the specific glycine receptor antagonist, strychnine. The drug was effective in all four convulsive tests at subanaesthetic doses with maximal activity appearing within less than 1 min. The anticonvulsive therapeutic indices of pregnanolone emulsion were superior when compared with the therapeutic indices of Althesin and thiopentone in all four tests. Pregnanolone emulsion might be a useful alternative drug in the management of convulsive states resistant to conventional therapy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3190973     DOI: 10.1093/bja/61.4.462

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  4 in total

Review 1.  Identification and characterization of a pregnane steroid recognition site that is functionally coupled to an expressed GABAA receptor.

Authors:  N C Lan; M B Bolger; K W Gee
Journal:  Neurochem Res       Date:  1991-03       Impact factor: 3.996

2.  In vitro and in vivo activity of 16,17-dehydro-epipregnanolones: 17,20-bond torsional energy analysis and D-ring conformation.

Authors:  M B Bolger; S Wieland; J E Hawkinson; H Xia; R Upasani; N C Lan
Journal:  Pharm Res       Date:  1996-10       Impact factor: 4.200

Review 3.  Treatment of epilepsy in women of reproductive age: pharmacokinetic considerations.

Authors:  James W McAuley; Gail D Anderson
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 4.  Neurosteroids and Focal Epileptic Disorders.

Authors:  Maxime Lévesque; Giuseppe Biagini; Massimo Avoli
Journal:  Int J Mol Sci       Date:  2020-12-10       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.